SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |
** = Publikationen gelistet in SCI/SSCI/Pubmed
** Beltran-Bless, AA; Clemons, MJ; Fesl, C; Greil, R; Pond, GR; Balic, M; Vandermeer, L; Bjelic-Radisic, V; Singer, CF; Steger, GG; Helfgott, R; Egle, D; Solkner, L; Gampenrieder, SP; Kacerovsky-Strobl, S; Suppan, C; Ritter, M; Rinnerthaler, G; Pfeiler, G; Fohler, H; Hlauschek, D; Hilton, J; Gnant, M
Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12
EUR J CANCER. 2023; 180: 108-116.
Doi: 10.1016/j.ejca.2022.12.003
Web of Science
PubMed
FullText
FullText_MUG
** Frudinger, A; Gauruder-Burmester, A; Graf, W; Lehmann, JP; Gunnarsson, U; Mihov, M; Ihnát, P; Kosorok, P; Orhalmi, J; Slauf, P; Emmanuel, A; Hristov, V; Jungwirthova, A; Lehur, PA; Müller, A; Amort, M; Marksteiner, R; Thurner, M
Skeletal Muscle-Derived Cell Implantation for the Treatment of Fecal Incontinence: A Randomized, Placebo-Controlled Study.
Clin Gastroenterol Hepatol. 2023; 21(2): 476-486.e8.
Doi: 10.1016/j.cgh.2022.07.039
Web of Science
PubMed
FullText
FullText_MUG
** Gold, D; Nicolay, L; Avian, A; Greimel, E; Balic, M; Pristauz-Telsnigg, G; Tamussino, K; Trutnovsky, G
Vaginal laser therapy versus hyaluronic acid suppositories for women with symptoms of urogenital atrophy after treatment for breast cancer: A randomized controlled trial.
Maturitas. 2023; 167: 1-7.
Doi: 10.1016/j.maturitas.2022.08.013
PubMed
FullText
FullText_MUG
** Naumann, G; Aigmuller, T; Bader, W; Bauer, R; Beilecke, K; Meier, CB; Bruer, G; Bschleipfer, T; Deniz, M; Fink, T; Gabriel, B; Grable, R; Grothoff, M; Haverkamp, A; Hampel, C; Henscher, U; Hubner, M; Huemer, H; Kociszewski, J; Kolbl, H; Kolle, D; Kropshofer, S; Kuhn, A; Nothacker, M; Oelke, M; Peschers, U; Preyer, O; Schultz-Lampel, D; Tamussino, K; Tholen, R; Tunn, R; Viereck, V; Reisenauer, C
Diagnosis and Therapy of Female Urinary Incontinence. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 015/091, January 2022) Part 2 with Recommendations on Interventional/Surgical Therapy of Overactive Bladder, Surgical Treatment of Stress Urinary Incontinence and Diagnosis and Therapy of Iatrogenic Urogenital Fistula
GEBURTSH FRAUENHEILK. 2023;
Doi: 10.1055/a-1967-1888
Web of Science
FullText
FullText_MUG
** Pujade-Lauraine, E; Brown, J; Barnicle, A; Wessen, J; Lao-Sirieix, P; Criscione, SW; du, Bois, A; Lorusso, D; Romero, I; Petru, E; Yoshida, H; Vergote, I; Colombo, N; Hietanen, S; Provansal, M; Schmalfeldt, B; Pignata, S; Martín, Lorente, C; Berton, D; Runnebaum, IB; Ray-Coquard, I
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.
JCO Precis Oncol. 2023; 7:e2200258
Doi: 10.1200/PO.22.00258
[OPEN ACCESS]
PubMed
FullText
FullText_MUG
** Taumberger, N; Gruber, T; Edler, K; Trutnovsky, G; Bracic, T; Semrl, N; Schütz, AM; Eisnecker, K; Tamussino, K; Fluhr, H
Female genital mutilation/cutting incidence, diagnostic capacities, and obstetric outcomes among migrant women: a single-center retrospective analysis in a 10-year birth cohort in Austria.
BMC Public Health. 2023; 23(1): 68
Doi: 10.1186/s12889-022-14773-7
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Naumann, G; Aigmuller, T; Bader, W; Bauer, R; Beilecke, K; Meier, CB; Bruer, G; Bschleipfer, T; Deniz, M; Fink, T; Gabriel, B; Grable, R; Grothoff, M; Haverkamp, A; Hampel, C; Henscher, U; Hubner, M; Huemer, H; Kociszewski, J; Kolbl, H; Kolle, D; Kropshofer, S; Kuhn, A; Nothacker, M; Oelke, M; Peschers, U; Preyer, O; Schultz-Lampel, D; Tamussino, K; Tholen, R; Tunn, R; Viereck, V; Reisenauer, C
Diagnosis and Therapy of Female Urinary Incontinence. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/091, January 2022) Part 1 with Recommendations on Diagnostics and Conservative and Medical Treatment
GEBURTSH FRAUENHEILK. 2023;
Doi: 10.1055/a-1967-1726
Web of Science
FullText
FullText_MUG